Article info

Download PDFPDF
Extended report
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation
  1. Correspondence to Erik Lubberts, Departments of Rheumatology and Immunology, Erasmus MC, University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands; e.lubberts{at}erasmusmc.nl
View Full Text

Citation

van Hamburg JP, Asmawidjaja PS, Davelaar N, et al
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation

Publication history

  • Received October 6, 2011
  • Accepted October 31, 2011
  • First published January 4, 2012.
Online issue publication 
March 02, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.